Medicamentos para artrite reumatoide fornecidos pelo Sistema Único de Saúde em 2019 no Brasil: estudo de coorte
Oliveira, Ana Liani Beisl; Lima, Elisangela Costa; Campos, Mônica; Luiza, Vera Lucia.
Ciênc. Saúde Colet. (Impr.)
; 28(5): 1443-1456, maio 2023. tab, graf
Artículo en Portugués |
LILACS-Express
| ID: biblio-1439816
Documentos relacionados
Drugs for rheumatoid arthritis provided by the Unified Health System in 2019 in Brazil: a cohort study.
Financing of health and the fiscal dependency of Brazilian municipalities between 2004 and 2019.
[Assessment of the municipal administration in the promotion of rational use of medicines in medium and large cities in Santa Catarina, Brazil].
[Coverage of the Brazilian Income Transfer Program and factors associated with the performance of dental procedures in Brazil, from 2007 to 2011: an ecological study].
[Hospital admissions due to neglected tropical diseases in Piauí, in the Northeast region of Brazil: costs, time trends, and spatial patterns, 2001-2018].
[Repercussions of the More Doctors Program in the Brazilian media after the Impeachment of 2016].
Monitoring of oral health teams after National Primary Care Policy 2017
Avaliação da gestão municipal na promoção do uso racional de medicamentos em municípios de médio e grande porte de Santa Catarina, Brasil
[Variability in Drug Procurement within Group 1B of the Pharmaceutical Specialized Scheme in Brazil].
Medicine dispensation in the prison system: Is pharmaceutical care assured?